Literature DB >> 8954786

Structure and chromosomal assignment of the human cyclin G gene.

Y Endo1, T Fujita, K Tamura, H Tsuruga, H Nojima.   

Abstract

Human cDNA and genomic DNA encoding cyclin G were cloned and analyzed. The amino acid sequence of cyclin G is well conserved among mammals. Human cyclin G (295 amino acids) has one extra Thr at residue 6 compared with rat and mouse cyclin G (294 amino acids). The genomic DNA for human cyclin G consists of six exons, and in the first intron, one distinct putative binding site for the p53 tumor suppressor gene product (GCACAAGCCCAGGCTAGTCC) was detected. We performed chromosome mapping utilizing the fluorescence in situ hybridization (FISH) technique using both cDNA and genomic DNA for cyclin G. FISH localizes human cyclin G to the 5q32-q34 region. In the vicinity of the chromosomal location of human cyclin G, four cases of chromosomal translocations in human hematopoietic tumors have been reported, such as a subgroup of chronic myelomonocytic leukemia, non-Hodgkin lymphoma, and acute lymphocytic leukemia. It is therefore important to examine whether chromosomal translocations around this region cause aberrant cyclin G expression in a manner that is causally related to leukemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954786     DOI: 10.1006/geno.1996.0598

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  4 in total

1.  Three assays show differences in binding of wild-type and mutant p53 to unique gene sequences.

Authors:  Uma Chandrachud; Susannah Gal
Journal:  Technol Cancer Res Treat       Date:  2009-12

2.  Whole genome expression profiling shows that BRG1 transcriptionally regulates UV inducible genes and other novel targets in human cells.

Authors:  Ling Zhang; Leah Nemzow; Hua Chen; Jennifer J Hu; Feng Gong
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

3.  Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells.

Authors:  K Watabe; A Ito; H Asada; Y Endo; T Kobayashi; K Nakamoto; S Itami; S Takao; Y Shinomura; T Aikou; K Yoshikawa; Y Matsuzawa; Y Kitamura; H Nojima
Journal:  Jpn J Cancer Res       Date:  2001-02

Review 4.  MicroRNA involvement in hepatocellular carcinoma.

Authors:  Laura Gramantieri; Francesca Fornari; Elisa Callegari; Silvia Sabbioni; Giovanni Lanza; Carlo M Croce; Luigi Bolondi; Massimo Negrini
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.